ZA982457B - Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin - Google Patents

Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin

Info

Publication number
ZA982457B
ZA982457B ZA982457A ZA982457A ZA982457B ZA 982457 B ZA982457 B ZA 982457B ZA 982457 A ZA982457 A ZA 982457A ZA 982457 A ZA982457 A ZA 982457A ZA 982457 B ZA982457 B ZA 982457B
Authority
ZA
South Africa
Prior art keywords
propanaminde
cyclodextrin
derivatives
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA982457A
Inventor
Joseph Geczy
Original Assignee
Therabel Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Research Sa filed Critical Therabel Research Sa
Publication of ZA982457B publication Critical patent/ZA982457B/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA982457A 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin ZA982457B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700632A HUP9700632A3 (en) 1997-03-24 1997-03-24 Pharmaceutical compositions containing propylamine derivative and cyclodextrine and process for producing the same

Publications (1)

Publication Number Publication Date
ZA982457B true ZA982457B (en) 1998-09-23

Family

ID=89994898

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982457A ZA982457B (en) 1997-03-24 1998-03-23 Pharmaceutical compositions containing propanaminde derivatives and cyclodextrin

Country Status (8)

Country Link
EP (1) EP0969874A1 (en)
JP (1) JP2002514210A (en)
AR (1) AR010910A1 (en)
AU (1) AU6848198A (en)
HR (1) HRP980155A2 (en)
HU (1) HUP9700632A3 (en)
WO (1) WO1998042382A1 (en)
ZA (1) ZA982457B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091192B1 (en) * 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
EP1109806B8 (en) * 1999-07-01 2003-10-29 Italfarmaco S.p.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates
ATE533513T1 (en) 2002-09-06 2011-12-15 Cerulean Pharma Inc POLYMERS BASED ON CYCLODEXTRIN FOR ADMINISTRATION OF COVALENTLY BONDED MEDICINAL PRODUCTS
JP2006516642A (en) * 2003-02-03 2006-07-06 シャイア ラボラトリーズ,インコーポレイテッド Drug formulation and delivery using methylated cyclodextrin crystals
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
WO2017191843A1 (en) * 2016-05-06 2017-11-09 一般財団法人バイオダイナミックス研究所 Polymerized drug-containing pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
WO1991013100A1 (en) * 1990-03-02 1991-09-05 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications

Also Published As

Publication number Publication date
HUP9700632A2 (en) 1998-12-28
HU9700632D0 (en) 1997-05-28
HRP980155A2 (en) 1998-12-31
EP0969874A1 (en) 2000-01-12
JP2002514210A (en) 2002-05-14
AU6848198A (en) 1998-10-20
WO1998042382A1 (en) 1998-10-01
AR010910A1 (en) 2000-07-12
HUP9700632A3 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL133613A0 (en) Epothilone derivatives and pharmaceutical compositions containing same
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL133293A0 (en) Pharmaceutical compositions comprising cyclodextrins
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
HUS1200028I1 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL135176A0 (en) Benzothiazole derivatives and pharmaceutical compositions containing the same
HUP0001541A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP0003362A2 (en) Piperidine derivatives and pharmaceutical compositions containing them
HUP9900424A2 (en) Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
IL135990A0 (en) Pharmaceutical compositions containing cyclodextrins and taxoids
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0002510A3 (en) Tetrazole derivatives and pharmaceutical compositions containing them
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof